Online Controlled Substances Summit 2025
September 11, 2025 | 12:30pm-3:30pm (Eastern)
Virtual Meeting
The Food and Drug Administration (FDA) and the Reagan-Udall Foundation are pleased to host the sixth Online Controlled Substances Summit. Illegal online sales of controlled substances pose significant health risks to consumers of all ages, especially our nation’s youth. As digital platforms evolve and access points expand, the need for cross-sector collaboration, research-informed strategies, and effective public education is critical.
This year’s Summit will explore emerging trends in the online ecosystem, including youth behaviors and platform usage, the human impact of uncontrolled access, and opportunities for intervention and risk reduction. Sessions featuring leadership from the FDA, patients and families and digital companies will highlight the latest research, including first-hand experiences from affected families and explore innovative strategic approaches from government, technology, and international partners.
Register today to join the 2025 Summit as we bring the community together to share insights, identify evolving threats and discuss innovative approaches to address this ongoing and complex public health concern.
Agenda
12:30pm |
Welcome & Opening RemarksSusan C. Winckler, RPh, Esq., CEO, Reagan-Udall Foundation for the FDA Grace Graham, MPP, Deputy Commissioner for Policy, Legislation, and International Affairs, U.S. Food and Drug Administration |
|---|---|
12:40pm |
Evolving ThreatSangeeta Vaswani Chatterjee, PharmD, Acting Director, Office of Drug Security, Integrity, and Response, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration Jake Ellis, Senior Operations Manager, Office of Criminal Investigations, U.S. Food and Drug Administration |
1pm |
Session 1: Research Updates and TrendsSaleem Alhabash, PhD, Associate Chair, Michigan State University Department of Advertising and Public Relations John Hertig, PharmD, Founder, Hertig Healthcare Advising, LLC Angie Hoth, PharmD, Research Consultant, Reagan-Udall Foundation for the FDA |
1:30pm |
Session 2: Human Impact of Online Access to Controlled SubstancesEd Ternan, President, Song for Charlie |
2pm |
Session 3: Strategies for Intervention/DisruptionMichael Carson, Senior Director, Regulatory Policy, eBay Jim Crotty, JD, Law Enforcement Outreach Manager, Meta Nate Feltner, JD, Principle Corporate Counsel, Microsoft Stephen Dufresne, Safety Operations Team Manager, Snapchat |
2:40pm |
Session 4: Global PerspectiveCarrie Harney, JD, Vice President, U.S. Government and Regulatory Affairs, US Pharmacopeia Matthew Nice, Global Program Manager, United Nations Laila Mouawad, Coordinator for International Cooperation, Anvisa International Affairs Office Ana Carolina Moreira Marino Araujo, Chief Advisor, Anvisa International Affairs Office |
3:15pm |
Closing RemarksSangeeta Vaswani Chatterjee, PharmD, Acting Director, Office of Drug Security, Integrity, and Response, Office of Compliance, Center for Drug Evaluation and Research, U.S. Food and Drug Administration Marta Sokolowska, PhD, Deputy Center Director for Substance Use and Behavioral Health, Center for Drug Evaluation and Research, U.S. Food and Drug Administration |
3:30pm |
Adjourn |